‘Latest Polio Outbreak Reveals Rare Risk of Oral Vaccine’ -NBC New York Report
https://www.nbcnewyork.com/news/national-international/us-polio-outbreak-linked-to-the-oral-vaccine-revealing-its-risks/3833258/?_osource=SocialFlowTwt_NYBrand
Salarius Pharmaceuticals Adds Two Mayo Clinic Sites To Its Ongoing Phase 1/2 Trial Of Seclidemstat As A Treatment For Ewing’s Sarcoma And FET-Rearranged Sarcomas
Expands Trial to 17 U.S. Sites and 25 Locations
Initiation of All Anticipated U.S. Trial Sites Largely Completed
HOUSTON, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a
Kronos Bio Announces First Patient Dosed In Phase 1b/2 Clinical Trial Of Lanraplenib In Combination With Gilteritinib In Acute Myeloid Leukemia
Kronos Bio, Inc. (NASDAQ:KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that the first patient has been dosed in a Phase 1b/2 clinical trial of lanraplenib in
Minerva Neurosciences Submits New Drug Application To FDA For Roluperidone For Treatment Of Negative Symptoms In Patients With Schizophrenia
Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that the company has
FDA Clears Insulet’s Omnipod 5 Automated Insulin Delivery System For Preschool Children
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D).
Travere Therapeutics And CSL Vifor Announce EMA Has Accepted For Review The Conditional Marketing Authorization Application For Sparsentan For The Treatment Of IgA Nephropathy
Travere Therapeutics, Inc. (NASDAQ:TVTX) and CSL Vifor today announced that the EMA has accepted for review the Conditional Marketing Authorization (CMA) application for sparsentan for the treatment of IgAN, a rare
Moderna To Supply 12M Doses Of Omicron-Containing Bivalent COVID-19 Booster Vaccines To The Government Of Canada
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Government of Canada has exercised its option to purchase an additional 4.5 million
EXCLUSIVE: Meet The 20 Year Old Who Made More On BBBY Stock Than Ryan Cohen
Ryan Cohen became a figurehead for the movement in Bed Bath & Beyond (NASDAQ: BBBY) shares, first announcing a stake of 9.8% in the retailer. New filings later revealed Cohen owned an 11.8% stake in Bed Bath that included stock and options.
Recap Of Friday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics’ (NASDAQ:AXSM) lead asset AUVELITY (dextromethorphan HBr -bupropion HCl)…